TY - JOUR
T1 - Parenteral nutrition-associated cholestasis
T2 - An American pediatric surgical association outcomes and clinical trials committee systematic review
AU - Rangel, Shawn J.
AU - Calkins, Casey M.
AU - Cowles, Robert A.
AU - Barnhart, Douglas C.
AU - Huang, Eunice Y.
AU - Abdullah, Fizan
AU - Arca, Marjorie J.
AU - Teitelbaum, Daniel H.
PY - 2012/1
Y1 - 2012/1
N2 - Objective: The aim of this study was to review evidence-based data addressing key clinical questions regarding parenteral nutrition-associated cholestasis (PNAC) and parenteral nutrition-associated liver disease (PNALD) in children. Data Source: Data were obtained from PubMed, Medicine databases of the English literature (up to October 2010), and the Cochrane Database of Systematic Reviews. Study Selection: The review of PNAC/PNALD has been divided into 4 areas to simplify one's understanding of the current knowledge regarding the pathogenesis and treatment of this disease: (1) nonnutrient risk factors associated with PNAC, (2) PNAC and lipid emulsions, (3) nutritional (nonlipid) considerations in the prevention of PNAC, and (4) supplemental medications in the prevention and treatment of PNAC. Results: The data for each topic area relevant to the clinical practice of pediatric surgery were reviewed, evaluated, graded, and summarized. Conclusions: Although the conditions of PNAC and PNALD have been well recognized for more than 30 years, only a few concrete associations and treatment protocols have been established.
AB - Objective: The aim of this study was to review evidence-based data addressing key clinical questions regarding parenteral nutrition-associated cholestasis (PNAC) and parenteral nutrition-associated liver disease (PNALD) in children. Data Source: Data were obtained from PubMed, Medicine databases of the English literature (up to October 2010), and the Cochrane Database of Systematic Reviews. Study Selection: The review of PNAC/PNALD has been divided into 4 areas to simplify one's understanding of the current knowledge regarding the pathogenesis and treatment of this disease: (1) nonnutrient risk factors associated with PNAC, (2) PNAC and lipid emulsions, (3) nutritional (nonlipid) considerations in the prevention of PNAC, and (4) supplemental medications in the prevention and treatment of PNAC. Results: The data for each topic area relevant to the clinical practice of pediatric surgery were reviewed, evaluated, graded, and summarized. Conclusions: Although the conditions of PNAC and PNALD have been well recognized for more than 30 years, only a few concrete associations and treatment protocols have been established.
KW - Lipid emulsion
KW - Liver disease
KW - Parenteral nutrition-associated cholestasis
UR - http://www.scopus.com/inward/record.url?scp=84855845481&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84855845481&partnerID=8YFLogxK
U2 - 10.1016/j.jpedsurg.2011.10.007
DO - 10.1016/j.jpedsurg.2011.10.007
M3 - Review article
C2 - 22244423
AN - SCOPUS:84855845481
SN - 0022-3468
VL - 47
SP - 225
EP - 240
JO - Journal of Pediatric Surgery
JF - Journal of Pediatric Surgery
IS - 1
ER -